Company description
ALTG is a biopharmaceutical company that focuses on developing treatments for autoimmune and rare diseases. The company is headquartered in San Diego, California and was founded in 2012. Their goal is to transform the lives of patients by bringing innovative therapies to the market. ALTG's pipeline includes multiple candidate drugs, with one in Phase 2b clinical trials for the treatment of alopecia areata, a rare autoimmune disease that causes hair loss. They also have a second candidate in pre-clinical development for another autoimmune disease, as well as several additional candidates in the research and development stage. The company has a strong management team with a track record of success in the biotech industry and partnerships with renowned research institutes and organizations. ALTG is dedicated to advancing their pipeline and making a positive impact in the lives of patients with rare diseases.